Last reviewed · How we verify

NCT07218055: AMEND

Assessment of Music Experiences in Navigating Depression Part 2

Recruiting now NA Last updated 20 October 2025
What this trial tests

NA trial testing Music therapy in Depression in 20 participants. Currently enrolling.

Timeline
8 September 2025
Primary endpoint
4 August 2026
4 August 2026

Quick facts

Lead sponsorIcahn School of Medicine at Mount Sinai
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposediagnostic
Enrollment20
Start date8 September 2025
Primary completion4 August 2026
Estimated completion4 August 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Icahn School of Medicine at Mount Sinai

Who can join

Adults 7 to 15, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is again looking at the use of music and music therapy experiences in navigating depression. The researchers will provide 11 sessions of music therapy and half will be followed by recitals at the Third Street School Music Settlement where the kids enrolled in our study will observe and interact with the performers and discuss and reflect on anxiety and performance and how sharing personal creativity affects them intra and interpersonally.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Music therapy

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Icahn School of Medicine at Mount Sinai trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07218055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing